Display options
Share it on

Front Neurol. 2014 Jun 02;5:89. doi: 10.3389/fneur.2014.00089. eCollection 2014.

Monitoring of Cerebral Blood Flow and Metabolism Bedside in Patients with Subarachnoid Hemorrhage - A Xenon-CT and Microdialysis Study.

Frontiers in neurology

Elham Rostami, Henrik Engquist, Ulf Johnson, Timothy Howells, Elisabeth Ronne-Engström, Pelle Nilsson, Lars Hillered, Anders Lewén, Per Enblad

Affiliations

  1. Section of Neurosurgery, Department of Neuroscience, Uppsala University , Uppsala , Sweden.
  2. Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University , Uppsala , Sweden.

PMID: 24917850 PMCID: PMC4041006 DOI: 10.3389/fneur.2014.00089

Abstract

Cerebral ischemia is the leading cause of morbidity and mortality following aneurysmal subarachnoid hemorrhage (SAH). Although 70% of the patients show angiographic vasospasm only 30% develop symptomatic vasospasm defined as delayed cerebral ischemia (DCI). Early detection and management of reversible ischemia is of critical importance in patients with SAH. Using a bedside Xenon enhanced computerized tomography (Xenon-CT) scanner makes it possible to measure quantitative regional Cerebral blood flow (CBF) bedside in the neurointensive care setting and intracerebral microdialysis (MD) is a method that offers the possibility to monitor the metabolic state of the brain continuously. Here, we present results from nine SAH patients with both MD monitoring and bedside Xenon-CT measurements. CBF measurements were performed within the first 72 h following bleeding. Six out of nine patients developed DCI at a later stage. Five out of six patients who developed DCI had initial global CBF below 26 ml/100 g/min whereas one had 53 ml/100 g/min. The three patients who did not develop clinical vasospasm all had initial global CBF above 27 ml/100 g/min. High lactate/pyruvate (L/P) ratio was associated with lower CBF values in the area surrounding the catheter. Five out of nine patients had L/P ratio ≥25 and four of these patients had CBF ≤ 22 ml/100 g/min. These preliminary results suggest that patients with initially low global CBF on Xenon-CT may be more likely to develop DCI. Initially low global CBF was accompanied with metabolic disturbances determined by the MD. Most importantly, pathological findings on the Xenon-CT and MD could be observed before any clinical signs of DCI. Combining bedside Xenon-CT and MD was found to be useful and feasible. Further studies are needed to evaluate if DCI can be detected before any other signs of DCI to prevent progress to infarction.

Keywords: Xenon-CT; cerebral blood flow; imaging; microdialysis; neurointensive care; subarachnoid hemorrhage; vasospasm

References

  1. J Neurosurg. 1990 Aug;73(2):266-73 - PubMed
  2. Pharmacol Rev. 1951 Mar;3(1):1-41 - PubMed
  3. Neurosurgery. 2003 Jun;52(6):1307-15; disacussion 1315-7 - PubMed
  4. Stroke. 1999 Jan;30(1):93-9 - PubMed
  5. Neuroradiology. 1988;30(4):283-92 - PubMed
  6. J Neuroimaging. 2012 Oct;22(4):408-15 - PubMed
  7. Neurosurgery. 2007 Oct;61(4):704-14; discussion 714-5 - PubMed
  8. J Neurotrauma. 2005 Jan;22(1):3-41 - PubMed
  9. Stroke. 1981 Nov-Dec;12(6):723-5 - PubMed
  10. J Neurol Neurosurg Psychiatry. 1997 May;62(5):512-6 - PubMed
  11. J Neurotrauma. 2009 Dec;26(12):2225-31 - PubMed
  12. Stroke. 1977 Jan-Feb;8(1):51-7 - PubMed
  13. Crit Care Med. 2000 Apr;28(4):984-90 - PubMed
  14. J Neurosurg. 1984 Aug;61(2):241-53 - PubMed
  15. Neurosurgery. 1989 Mar;24(3):368-72 - PubMed
  16. Br J Neurosurg. 2005 Oct;19(5):395-401 - PubMed
  17. Stroke. 2000 Jul;31(7):1621-7 - PubMed
  18. Neurocrit Care. 2011 Sep;15(2):211-40 - PubMed
  19. Neurosurgery. 1999 Nov;45(5):1176-84; discussion 1184-5 - PubMed
  20. Stroke. 1988 Oct;19(10):1300-5 - PubMed
  21. Neurosurg Clin N Am. 1996 Oct;7(4):605-16 - PubMed
  22. J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):77-83 - PubMed
  23. Acta Neurol Scand. 2004 Jan;109(1):25-32 - PubMed
  24. J Cereb Blood Flow Metab. 1991 Sep;11(5):716-25 - PubMed
  25. Crit Care Med. 1995 Jun;23(6):1007-17 - PubMed
  26. Curr Pharm Des. 2004;10(18):2145-52 - PubMed
  27. J Cereb Blood Flow Metab. 1996 Jul;16(4):637-44 - PubMed
  28. Br J Anaesth. 2012 Sep;109(3):315-29 - PubMed
  29. Curr Neurovasc Res. 2012 Nov;9(4):310-9 - PubMed
  30. Lancet. 1984 Jun 16;1(8390):1357 - PubMed
  31. Neurol Med Chir (Tokyo). 1990 May;30(5):309-16 - PubMed
  32. N Engl J Med. 1997 Jan 2;336(1):28-40 - PubMed
  33. Stroke. 2004 Mar;35(3):638-43 - PubMed
  34. Nord Med. 1998 Feb;113(2):49-52 - PubMed
  35. J Neurosurg. 2001 Mar;94(3):397-402 - PubMed
  36. Br J Neurosurg. 2007 Aug;21(4):332-9 - PubMed
  37. Stroke. 2001 Jul;32(7):1574-80 - PubMed
  38. Acta Neurochir Suppl. 2001;77:149-53 - PubMed
  39. J Neurosurg. 1965 Jan;22:21-9 - PubMed
  40. Acta Neurochir Suppl. 2005;95:123-7 - PubMed
  41. J Neurosurg. 1996 Apr;84(4):606-16 - PubMed
  42. AJNR Am J Neuroradiol. 2011 Aug;32(7):1315-20 - PubMed
  43. Stroke. 1984 May-Jun;15(3):443-50 - PubMed

Publication Types